By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
latest_posts
- 1
Don't miss these five impressive spots in Bangkok - 2Figure out how to Arrange a Fair Settlement with the Assistance of a Fender bender Legal counselor
- 3Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
- 4I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- 5Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission.
- Italy Brings In New Measures In 2026 To Tackle Overtourism
- ‘And then we saw the little head.’ Scientists witness rare sperm whale birth
- See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- Productive CRM Programming for Client Relationship The executives
- Ancient mass grave discovered in water cistern during Tel Azekah excavations
- 4 Sound blocking Earphones for Prevalent Sound and Solace
- Want to read more in 2026? Here's how to revive your love of books
- Grasping the Course of Evacuation and Extradition in U.S. Migration
